Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-27

Clinical Trial Update: A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne [Phase 4]

View source ↗

Summary

This Phase 4 study compares Aczone (dapsone) plus Differin (adapalene) versus Duac (benzoyl peroxide/adapalene) plus Differin in patients with severe facial acn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACZONE (DAPSONE)
  • DIFFERIN (ADAPALENE)
  • Duac (benzoyl peroxide/adapalene)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2012-07-27